Léim chuig an ábhar
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Teanga
Gach réimse
Teideal
Údar
Ábhar
Gairmuimhir
ISBN/ISSN
Clib
AIMSIGH
CASTA
Paraoxonase polymorphism MET-L...
Luaigh é seo
Seol mar théacs é seo
Seol é seo mar r-phost
Priontáil
Easpórtáil taifead
Easpórtáil chuig RefWorks
Easpórtáil chuig EndNoteWeb
Easpórtáil chuig EndNote
Buan-nasc
Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:
Groves, C
,
Horton, V
,
Ritchie, A
,
Owen, R
,
Stratton, I
,
Green, F
,
Holman, R
,
Turner, R
Formáid:
Journal article
Foilsithe / Cruthaithe:
1998
Stoc
Cur síos
Míreanna comhchosúla
Amharc foirne
Míreanna comhchosúla
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
de réir: Stevens, R, et al.
Foilsithe / Cruthaithe: (2004)
Silent myocardial infarction is an independent risk factor for fatal myocardial infarction in patients with Type 2 diabetes
de réir: Cull, C, et al.
Foilsithe / Cruthaithe: (2007)
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations
de réir: Ilia Leviev, et al.
Foilsithe / Cruthaithe: (2001-04-01)
Serum myeloperoxidase, paraoxonase, and plasma asprosin concentrations in patients with acute myocardial infarction
de réir: Handan Ciftci, et al.
Foilsithe / Cruthaithe: (2024-04-01)
UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
de réir: Keavney, B, et al.
Foilsithe / Cruthaithe: (1995)